Nucleic Acid Standards for Biosecurity Act

# Nucleic Acid Standards for Biosecurity Act (HR 3029) – Summary **What the Bill Would Do** This bill would establish federal standards and oversight for the synthesis of nucleic acids (DNA and RNA molecules). If passed, it would likely require companies and laboratories that produce these biological materials to implement safety measures and screening procedures to prevent their misuse for creating dangerous biological agents or weapons. The bill aims to balance scientific research needs with biosecurity concerns—ensuring legitimate researchers can access these materials while preventing bad actors from obtaining them for harmful purposes. **Who It Affects and Key Provisions** The bill would primarily impact synthetic biology companies, research institutions, diagnostic laboratories, and academic centers that produce or use synthetic nucleic acids. While specific provisions aren't detailed in this summary, bills of this type typically include requirements for screening orders, maintaining customer records, reporting suspicious requests, and adhering to best practices in biosecurity.

Legitimate researchers and companies would need to comply with new regulations, though provisions usually include exceptions for approved scientific work. **Current Status** As of now, HR 3029 remains in committee, meaning it has not yet been voted on by the full House. The bill was introduced by Representative Andrea Salinas (D-Oregon) in the 119th Congress. No action has advanced it beyond the committee stage at this time.